Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 0 | 57 | 28 | 5 | 447 |
| Gross Profit | N/A | 57 | 28 | 5 | 447 |
| Operating Expenses | 17,540 | 12,378 | 19,673 | 15,045 | 8,702 |
| Operating Income | -17,540 | -12,321 | -19,645 | -15,040 | -8,255 |
| Interest Expense | 4,735 | 1 | 3,903 | 960 | 14 |
| Other Income | 81 | -2,637 | 4,481 | 3,668 | -1,761 |
| Pre-tax Income | -22,195 | -14,959 | -19,067 | -12,332 | -10,030 |
| Income Tax | 3 | 4 | N/A | N/A | N/A |
| Net Income Continuous | -22,198 | -14,963 | -19,067 | -12,332 | -10,030 |
| Net Income | $-22,198 | $-14,963 | $-19,067 | $-12,332 | $-10,030 |
| EPS Basic Total Ops | -1.98 | -1.24 | -2.33 | -3.12 | -4.89 |
| EPS Basic Continuous Ops | -1.98 | -1.22 | -2.28 | -3.12 | -2.93 |
| EPS Diluted Total Ops | -1.98 | -1.24 | -2.33 | -3.12 | -4.89 |
| EPS Diluted Continuous Ops | -1.98 | -1.22 | -2.28 | -3.12 | -2.93 |
| EPS Diluted Before Non-Recurring Items | -1.47 | -0.99 | -2.68 | -4.00 | -4.50 |
| EBITDA(a) | $-17,018 | $-8,379 | $-15,406 | $-14,351 | $-8,207 |